Author:
Tothfalusi Laszlo,Endrenyi Laszlo
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Haidar SH, Davit BM, Chen M-L, Conner D, Lee LM, Li QH, et al. Bioequivalence approaches for highly variable drugs and drug products. Pharm Res. 2008;25:237–41.
2. Hyslop T, Hsuan F, Holder DJ. A small sample confidence interval approach to assess individual bioequivalence. Stat Med. 2000;19(20):2885–97.
3. Tothfalusi L, Endrenyi L, Arieta AG. Evaluation of bioequivalence for highly variable drugs with scaled average bioequivalence. Clin Pharmacokinet. 2009;48:725–43.
4. FDA. Draft guidance for industry: statistical approaches to establishing bioequivalence. Rockville: Center for Drug Evaluation and Research (CDER); 2001.
5. FDA. Draft guidance for industry: bioequivalence recommendations for progesterone oral capsules. Silver Spring: Center for Drug Evaluation and Research (CDER); 2011.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献